Clinical Trials Logo

Clinical Trial Summary

- Background : Ephrin-B1 is part of the large Eph/Ephrin system which is involved in cell-cell comunication. The role of Ephrin-B1 has scarcely been studied in adulthood. Our team has shown that this protein is expressed in normal heart in mice and humans. In mice with deletion of the gene encoding Ephrin-B1, we have shown progressive development of dilated cardiomyopathy characterized by dramatic disorganization of cardiac tissue architecture and decreased heart rate variability.

- Purpose: Ephrin-B1 protein was recently identified in human heart but its putative role remains unknown. In knockout mice, deletion of efn gene is associated with abnormalities in cardiac architecture linked to defects in cell-cell tight junctions. From a functional point of view, mice develop a dilated cardiomyopathy and exhibit decreased heart rate variability in the frequency domain. The purpose of this study is to assess if Ephrin-B1 expression is regulated in human heart and if expression level correlates with heart rate variability.

- Abstract: Thirty patients suffering from cardiac disease needing surgery will be included and separated in two groups according to pressure levels in right auricle /and or pulmonary artery. Ephrin-B1 expression will be assessed in right appendages at both the transcriptional (quantitative PCR) and protein (Western blot) levels. Furthermore, the putative relationship between Ephrin-B1 expression and heart rate variability (24 hours ECG recordings) will be investigated.


Clinical Trial Description

- Outcomes

- Primary: Expression level of gene encoding Ephrin B1 (quantitative PCR normalized against GAPDH gene expression) on human right appendage biopsies

- Secondary: a/ Expression level of Ephrin B1 protein on human right appendage using Western blot and b/ Heart rate variability in both time and spectral domains

- Study design: Exploratory, monocentric , prospective and comparative. Two groups of 15 patients each, age and sex matched, with or without elevated pressures in right auricles or pulmonary arteries will be included.

- Eligibility criteria:

- Inclusion criteria: patients needing cardiac surgery and who had both right catheterism and 24 hours ECG recording before inclusion; stable medications for at least 4 weeks; age > 18 years.

- Exclusion criteria: Patient with pace-maker or atrial fibrillation

- Number of subjects: 30 patients in two groups of 15 patients each.

- Statistical analysis: Qualitative and quantitative variables will be compared using McNemar test and t test respectively. A p value < 0.05 will be considered as significant. ;


Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01080781
Study type Observational
Source University Hospital, Toulouse
Contact
Status Completed
Phase N/A
Start date March 2010
Completion date December 2012

See also
  Status Clinical Trial Phase
Terminated NCT00176657 - The Use of HEMOBAG to Salvage Blood After Cardiac Surgery Phase 2
Completed NCT00027001 - Qigong Therapy For Heart Device Patients N/A
Terminated NCT04398017 - MEOPA-coupled Hypnosis Versus MEOPA-standard Care in Transesophageal Echocardiography N/A
Completed NCT00296738 - 123I-MIBG SPECT/CT for Assessment of Cardiac Sympathetic Innervation Phase 0
Completed NCT00661752 - Protocol for Evaluation of Quarter-Time Cardiac Imaging: 5-Minutes Rest and 3-Minutes Stress Wide Beam Reconstruction (WBR) Versus Full-Time Filtered Back Projection (FBP) N/A
Completed NCT00293592 - Dexamethasone for Cardiac Surgery Trial N/A
Completed NCT00011310 - Cardiopulmonary Effects of Particulate Exposure N/A
Completed NCT02727634 - Ultrapower; a Minimally Invasive Tool for Evaluation of Total Cardiac Power N/A
Completed NCT01639313 - Comparison of Nexfin Pulse Contour Analysis and Cardiac Magnetic Resonance Imaging for the Measurement of Cardiac Output N/A
Completed NCT00945048 - Non-Invasive Determination of Cardiac Output by Electrical Velocimetry N/A
Completed NCT00281424 - Increasing Walking Following Cardiac Rehabilitation Phase 2/Phase 3
Not yet recruiting NCT06409481 - Pharmacovigilance Assessment of Reporting of Cardiovascular Adverse Events With Antineoplastic Agents (PARCA)
Completed NCT02723890 - The Efficacy and Safety of Using the Novel Tyto Device N/A
Completed NCT01165515 - Endostatin Serum Levels During Bicycle Stress Test N/A
Recruiting NCT05051254 - Respiratory Muscles and Work of Breathing in Children N/A
Completed NCT01683448 - The Effect of Perioperative Medications on the Outcomes of Patients Undergoing Cardiac Surgery
Terminated NCT00229892 - Incisions for Cardiac Surgery N/A
Completed NCT02802254 - Increasing Risk Perception of Physical Activity Using Patient-targeted Feedback. Phase 2/Phase 3
Completed NCT02159014 - DanceFit Prime: A Dance Based Physical Activity and Nutritional Intervention for Primary Care - A Feasibility Study N/A
Completed NCT00464126 - The Use of Colloid Versus Crystalloid in Post-operative Pediatric Cardiac Patients for Fluid Resuscitation N/A